1. Home
  2. VKTX vs REZI Comparison

VKTX vs REZI Comparison

Compare VKTX & REZI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VKTX
  • REZI
  • Stock Information
  • Founded
  • VKTX 2012
  • REZI 2018
  • Country
  • VKTX United States
  • REZI United States
  • Employees
  • VKTX N/A
  • REZI N/A
  • Industry
  • VKTX Biotechnology: Pharmaceutical Preparations
  • REZI Wholesale Distributors
  • Sector
  • VKTX Health Care
  • REZI Industrials
  • Exchange
  • VKTX Nasdaq
  • REZI Nasdaq
  • Market Cap
  • VKTX 2.8B
  • REZI 2.7B
  • IPO Year
  • VKTX 2015
  • REZI N/A
  • Fundamental
  • Price
  • VKTX $26.12
  • REZI $20.61
  • Analyst Decision
  • VKTX Buy
  • REZI Hold
  • Analyst Count
  • VKTX 12
  • REZI 1
  • Target Price
  • VKTX $84.00
  • REZI $16.00
  • AVG Volume (30 Days)
  • VKTX 2.8M
  • REZI 966.6K
  • Earning Date
  • VKTX 07-23-2025
  • REZI 05-06-2025
  • Dividend Yield
  • VKTX N/A
  • REZI N/A
  • EPS Growth
  • VKTX N/A
  • REZI N/A
  • EPS
  • VKTX N/A
  • REZI 0.30
  • Revenue
  • VKTX N/A
  • REZI $7,045,000,000.00
  • Revenue This Year
  • VKTX N/A
  • REZI $11.43
  • Revenue Next Year
  • VKTX N/A
  • REZI $3.45
  • P/E Ratio
  • VKTX N/A
  • REZI $68.16
  • Revenue Growth
  • VKTX N/A
  • REZI 14.02
  • 52 Week Low
  • VKTX $18.92
  • REZI $14.18
  • 52 Week High
  • VKTX $81.73
  • REZI $28.28
  • Technical
  • Relative Strength Index (RSI)
  • VKTX 45.41
  • REZI 61.38
  • Support Level
  • VKTX $26.66
  • REZI $19.65
  • Resistance Level
  • VKTX $28.33
  • REZI $20.92
  • Average True Range (ATR)
  • VKTX 1.37
  • REZI 0.45
  • MACD
  • VKTX -0.20
  • REZI -0.09
  • Stochastic Oscillator
  • VKTX 9.58
  • REZI 46.83

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

About REZI Resideo Technologies Inc.

Resideo Technologies Inc is a manufacturer and developer of technology-driven products and components that provide critical comfort, energy management, and safety and security solutions. The company has two reportable segments; Products and Solutions segment offers temperature and humidity control, energy products and solutions, water and air solutions, smoke and carbon monoxide detection home safety products, security panels, sensors, peripherals, wire and cable, communications devices, video cameras, other home-related lifestyle convenience solutions; and ADI Global Distribution segment includes wholesale distributor of low-voltage security products including access control, fire detection, security, and video products. It derives majority of its revenue from the United States.

Share on Social Networks: